Abstract:
Explained 777(i.e. 183) – 338(i.e. 250 + 87 with a directional difference of 1) = 439 where 43*34 = 562(under suppression) = 900 – 338 and 705(lunar gravity) – 562(balanced time values) = 143 or 934 in the structure.
Again, 562 + 27(electron time) = 589 where 58*85 = 4930 or 430(under suppression) shows directional change ‘9’ i.e. 0.0171 or 171 according to formula T(time) = 0.0019M(mass) in 439. In dimensional context, 425(electromagnetic time values i.e. 387 + 38 where 513(27) + 387 = 900 and 38 exists beyond 900 in proton molecular weight) + 352(halved of lunar gravity) = 777 and 425 – 352 = 73 = 777 – 705 with a directional difference of 1.
Estrogen or Estradiol(272.380 g/mol): Here, 380 – 272 = 108 = 9(directional change) + 99(i.e. 72 + 27) causing TNBC needed directional change of either 72 or 27 for prospective remedies. Structurally, 352 + 9 = 361(halved of 522 = 705 – 183) + 107(would be electro-gravitational influx into the system) towards proliferation = 468(i.e. 72, neutralization adverse effects) where 352 + 107 = 459(blocked) and 901 – 352 = 549 in the structure.
Progesterone(314.469): Here, 469 – 314 = 155 = 164 – 9(directional change) where 736(oxy-time 329) + 164 = 900 that related to oxygen. In opposite direction, 777 + 705 = 1482 or 582 where 582 – 318 = 264 = 164 +100(i.e. 72+27+1).
Lapatinib(943.480 g/mol): Here, 943 = 513(27) + 430 where 513 – 430 = 83 = 563 – 480 is a useful drug. In a way, 561 – 425 = 136 or 927 where 927 – 475 = 452 = 559 - 107 may be an implementation.
Tucatinib(480.520): Here, 520 – 480 = 40 = 562 – 522 and conversely 927 – 888 = 39 where 900 – 888 = 12.
Bortezomib(384.240): Here, 384 – 352 = 32 and 384 + 41 = 425 where 41 – 32 = 9 and 41+ 32 = 73. Also, 736(i.e. 239 or 240) -32 = 704 and 736 + 41 = 777 that linked to ROS. Also, 384 + 179 = 563 where 179 would be blocking values of 171(9) while molecular weight of carfilzomib is 719.91.
